| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print December 3, 2001
Pharmacology, Boston University School of Medicine, Boston, MA 02118
Corresponding Author: yafliu{at}bu.edu
We previously reported that normal huntingtin is associated with epidermal growth factor receptor (EGF) signaling complex (1). To investigate the potential role of normal and polyglutamine-expanded huntingtin in the regulation of growth factor receptor-mediated cellular signaling and biological function, we stably transfected full-length huntingtin containing 16, 48, or 89 polyglutamine repeats into PC12 cells where cellular signaling mechanisms, mediated by nerve growth factor (NGF) or EGF receptors, are well characterized. Expression of polyglutamine-expanded huntingtin, but not normal huntingtin, leads to a dramatic morphological change. In clones carrying the mutated huntingtin, both NGF and EGF-receptor-mediated activation of mitogen-activated protein kinase (MAPK), c-Jun-N-terminal kinase (JNK) and Akt is significantly attenuated, and NGF receptor-mediated neurite outgrowth is blocked. Co-immunoprecipitation studies show that the associations of NGF or EGF receptors with growth factor receptor binding protein 2 (Grb2) and phosphoinositide 3 (PI-3) kinase are significantly inhibited. NGF-induced tyrosine phosphorylation of NGF receptors (trkA) is also consistently suppressed. Our data demonstrate that polyglutamine-expanded huntingtin disrupts cellular signaling mediated by both EGF and NGF receptors in PC12 cells. It is known that HD patients exhibit an extremely low incidence of a variety of cancers and are deficient in glucose metabolism. Thus, our results may reflect an important molecular mechanism for the pathogenesis of the disease.
J. Biol. Chem, 10.1074/jbc.M110338200
Submitted on October 26, 2001
Revised on November 27, 2001
Accepted on December 3, 2001
Expression of full-length polyglutamine-expanded huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-C. Lievens, M. Iche, M. Laval, C. Faivre-Sarrailh, and S. Birman AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease Hum. Mol. Genet., March 15, 2008; 17(6): 882 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Varma, R. Cheng, C. Voisine, A. C. Hart, and B. R. Stockwell Inhibitors of metabolism rescue cell death in Huntington's disease models PNAS, September 4, 2007; 104(36): 14525 - 14530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Scappini, T.-W. Koh, N. P. Martin, and J. P. O'Bryan Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase Hum. Mol. Genet., August 1, 2007; 16(15): 1862 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rong, J. R. McGuire, Z.-H. Fang, G. Sheng, J.-Y. Shin, S.-H. Li, and X.-J. Li Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J. Neurosci., May 31, 2006; 26(22): 6019 - 6030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Apostol, K. Illes, J. Pallos, L. Bodai, J. Wu, A. Strand, E. S. Schweitzer, J. M. Olson, A. Kazantsev, J. L. Marsh, et al. Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity Hum. Mol. Genet., January 15, 2006; 15(2): 273 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Sugars, R. Brown, L. J. Cook, J. Swartz, and D. C. Rubinsztein Decreased cAMP Response Element-mediated Transcription: AN EARLY EVENT IN EXON 1 AND FULL-LENGTH CELL MODELS OF HUNTINGTON'S DISEASE THAT CONTRIBUTES TO POLYGLUTAMINE PATHOGENESIS J. Biol. Chem., February 6, 2004; 279(6): 4988 - 4999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Song, Y. Zhang, C. G. Parsons, and Y. F. Liu Expression of Polyglutamine-expanded Huntingtin Induces Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptors J. Biol. Chem., August 29, 2003; 278(35): 33364 - 33369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Li, Z.-X. Yu, C.-L. Li, H.-P. Nguyen, Y.-X. Zhou, C. Deng, and X.-J. Li Lack of Huntingtin-Associated Protein-1 Causes Neuronal Death Resembling Hypothalamic Degeneration in Huntington's Disease J. Neurosci., July 30, 2003; 23(17): 6956 - 6964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Holbert, A. Dedeoglu, S. Humbert, F. Saudou, R. J. Ferrante, and C. Neri Cdc42-interacting protein 4 binds to huntingtin: Neuropathologic and biological evidence for a role in Huntington's disease PNAS, March 4, 2003; 100(5): 2712 - 2717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-L. Wu, T. M. O'Kane, R. W. Scott, M. J. Savage, and D. Bozyczko-Coyne Protein Tyrosine Phosphatases Are Up-regulated and Participate in Cell Death Induced by Polyglutamine Expansion J. Biol. Chem., November 8, 2002; 277(46): 44208 - 44213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fossale, V. C. Wheeler, V. Vrbanac, L.-A. Lebel, A. Teed, J. S. Mysore, J. F. Gusella, M. E. MacDonald, and F. Persichetti Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice Hum. Mol. Genet., September 15, 2002; 11(19): 2233 - 2241. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
